Message from CEO

Welcome to HMI Group.

Founded in 1998, HMI Group (“Group”) was listed on SGX Catalist on 15 October 1999 and upgraded to the SGX Mainboard on 10 March 2008. Today, we are a growing regional healthcare provider that owns two tertiary hospitals in Malaysia, a healthcare training institute as well as a new one-stop ambulatory care centre in Singapore. We are committed to not just improving the lives of our patients, but the community as a whole by leveraging on our human capital, consistent innovation and technological expertise. Recently delisted from the Singapore Stock Exchange, HMI can further strengthen its business expansion and its vision of being a leading healthcare group in Asia

In June 2018, the Group initiated a rebranding exercise to refresh its Vision and Mission while embarking on its next phase of growth to become a leading healthcare group in Asia. With a new corporate identity and logo, the Group renewed its pledge to serve the community through provision of quality healthcare with a heartfelt human touch. With an enlarged healthcare platform under, we are now focused on our regional growth strategies with greater focus on operational and service excellence, as well as continual investment in cutting-edge technology and people.

Since our inception, we have always engaged with the community, striving to educate and empower its members to take better care of their health by advocating the prevention of diseases through healthy living. To date, our HMI Institute has trained more than 4,500 healthcare professionals and 160,000 individuals in Emergency life-saving skills. Together, we are building a healthier society.

Demographic changes such as rising affluence, an ageing population and wider insurance coverage have led to an increase in demand for healthcare across the region. To further organic growth and to cater to increasing patient load, both our hospitals are undergoing further expansion works. At Mahkota Medical Centre, we have expanded the radiology and other departments for more clinical area. Regency Specialist Hospital (“Regency”) will commence the construction of a new hospital extension block adjacent to its existing hospital block, pending necessary approvals. The new block will add more inpatient beds, clinical services, operating theatres and clinic suites. Upon its completion, Regency will become a 380-bed tertiary hospital with capacity to expand to an eventual 500-bed hospital.

In May 2018, we invested in StarMed Specialist Centre (“StarMed”), our new one-stop multidisciplinary ambulatory care centre in Singapore. StarMed focuses on cardio-vascular (heart & lungs), digestive (gut), minimally invasive surgeries and diagnostic services.  We envisage StarMed to be competitively priced, providing quality private healthcare that is affordable and accessible for local and foreign patients.

We hope you will follow us on our journey in Advancing Healthcare, Changing Lives! Please visit our website regularly to stay up to date with our latest corporate developments.